Fertility drugs, reproductive strategies and ovarian cancer risk

被引:0
|
作者
Federica Tomao
Giuseppe Lo Russo
Gian Paolo Spinelli
Valeria Stati
Alessandra Anna Prete
Natalie Prinzi
Marsela Sinjari
Patrizia Vici
Anselmo Papa
Maria Stefania Chiotti
Pierluigi Benedetti Panici
Silverio Tomao
机构
[1] University of Rome “Sapienza”,Department of Gynaecological and Obstetrical Sciences and Urological Sciences
[2] University of Rome “Sapienza,Department of Medico
[3] ”,Surgical Sciences and Biotechnologies
[4] University of Rome “Sapienza”,Department of Experimental Medicine
[5] National Cancer Institute of Rome,Department of Medical Oncology
关键词
Fertility drugs; Ovarian cancer; Ovarian stimulation; fertilization; Clomiphene citrate;
D O I
暂无
中图分类号
学科分类号
摘要
Several adverse effects have been related to infertility treatments, such as cancer development. In particular, the relationship between infertility, reproductive strategies, and risk of gynecological cancers has aroused much interest in recent years. The evaluation of cancer risk among women treated for infertility is very complex, mainly because of many factors that can contribute to occurrence of cancer in these patients (including parity status). This article addresses the possible association between the use of fertility treatments and the risk of ovarian cancer, through a scrupulous search of the literature published thus far in this field. Our principal objective was to give more conclusive answers on the question whether the use of fertility drug significantly increases ovarian cancer risk. Our analysis focused on the different types of drugs and different treatment schedules used. This study provides additional insights regarding the long-term relationships between fertility drugs and risk of ovarian cancer.
引用
收藏
相关论文
共 50 条
  • [1] Fertility drugs, reproductive strategies and ovarian cancer risk
    Tomao, Federica
    Lo Russo, Giuseppe
    Spinelli, Gian Paolo
    Stati, Valeria
    Prete, Alessandra Anna
    Prinzi, Natalie
    Sinjari, Marsela
    Vici, Patrizia
    Papa, Anselmo
    Chiotti, Maria Stefania
    Panici, Pierluigi Benedetti
    Tomao, Silverio
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [2] Use of fertility drugs and risk of ovarian cancer
    Parazzini, F
    Pelucchi, C
    Negri, E
    Franceschi, S
    Talamini, R
    Montella, M
    La Vecchia, C
    HUMAN REPRODUCTION, 2001, 16 (07) : 1372 - 1375
  • [3] FERTILITY DRUGS AND RISK OF OVARIAN-CANCER
    WHITTEMORE, AS
    HUMAN REPRODUCTION, 1993, 8 (07) : 999 - 1000
  • [5] Use of fertility drugs and risk of ovarian cancer
    Diergaarde, Brenda
    Kurta, Michelle L.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (03) : 125 - 129
  • [6] Fertility drugs 'do not increase risk of ovarian cancer'
    不详
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (07) : 1096 - 1096
  • [7] Fertility drugs and risk of ovarian cancer: dispelling the myth
    Zreik, Tony G.
    Ayoub, Chakib M.
    Hannoun, Antoine
    Karam, Cynthia J.
    Munkarah, Adnan R.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2008, 20 (03) : 313 - 319
  • [8] Fertility drugs and ovarian cancer
    Artini, PG
    Fasciani, A
    Cela, V
    Battaglia, C
    deMicheroux, AA
    DAmbrogio, G
    Genazzani, AR
    GYNECOLOGICAL ENDOCRINOLOGY, 1997, 11 (01) : 59 - 68
  • [9] Fertility drugs and ovarian cancer
    Glud, E
    Kjær, SK
    Troisi, R
    Brinton, LA
    EPIDEMIOLOGIC REVIEWS, 1998, 20 (02) : 237 - 257
  • [10] Fertility Drugs and Ovarian Cancer
    Ali, Aus Tariq
    CURRENT CANCER DRUG TARGETS, 2018, 18 (06) : 567 - 576